Kelly CRISPR & Gene Editing Technology ETF (XDNA) News Today $7.38 0.00 (0.00%) (As of 07/26/2024 ET) Add Compare Share Share HeadlinesStock AnalysisChartHeadlinesHoldingsOptions ChainRatingsTrendsStock AnalysisChartHeadlinesHoldingsOptions ChainRatingsTrends All Sources Trusted Sources MarketBeat.com Benzinga Bloomberg MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha The Street The Wall Street Journal Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 September 2022 August 2022 July 2022 June 2022 May 2022 April 2022 March 2022 February 2022 January 2022 December 2021 November 2021 October 2021 September 2021 August 2021 Time Period May 15, 2024 | msn.comCRISPR can treat common form of inherited blindness, early data hintMarch 9, 2024 | markets.businessinsider.comCRISPR Technology Takes Center Stage at SXSW 2024 for the First TimeFebruary 15, 2024 | markets.businessinsider.comIntellia Collaborates With ReCode To Develop Gene Therapy For Cystic FibrosisJanuary 15, 2024 | msn.comHere's Why CRISPR Therapeutics Stock Rose 54% Last YearDecember 8, 2023 | news.yahoo.comGene editing is now a medical realityDecember 8, 2023 | news.yahoo.comFDA approves first use of CRISPR gene editing to treat sickle cell diseaseDecember 8, 2023 | markets.businessinsider.comFDA Approves First Gene-Editing Cell Therapy For Sickle Cell Disease, An Inherited Blood DisorderNovember 24, 2023 | msn.comGene Editing Will Change Medicine—and Maybe Health Investing TooNovember 22, 2023 | msn.comIs CRISPR Therapeutics the Best Gene-Editing Stock?November 9, 2023 | markets.businessinsider.com3 Biotech Stocks That Are Betting on the Future of Gene EditingOctober 30, 2023 | msn.comCRISPR gene editing could kill HIV. But is it a cure?October 17, 2023 | msn.comCantor Fitzgerald Downgrades CRISPR Therapeutics (CRSP)August 3, 2023 | finance.yahoo.comCRISPR Market is Expected to Reach $7.1 Billion | MarketsandMarkets.July 16, 2023 | benzinga.comGene Editing Market worth $10.6 billion | MarketsandMarketsMay 31, 2023 | msn.comCRISPR Therapeutics: A Galaxy's Worth of Deep ValueMay 19, 2023 | benzinga.comGlobal Gene Editing Technologies Market to Reach $16.37 Billion by 2032 - Exclusive DeepTech M-A-P™ Analysis by BIS ResearchMay 14, 2023 | uk.investing.comKelly CRISPR & Gene Editing Technology ETF (XDNA)April 21, 2023 | nasdaq.comGuide to the First Ever FDA CRISPR Approval Expected this Year by CRISPR & Vertex (XDNA ETF Companies)April 17, 2023 | money.usnews.comMegatrends: Gene Therapy and EditingMarch 21, 2023 | marketwatch.comGene Editing Tools Market Outlook, Share, Prominent Players, Size, Growth, and Forecast 2023 to 2031March 11, 2023 | cnn.comHow human gene editing is moving on after the CRISPR baby scandalFebruary 11, 2023 | benzinga.comGlobal Advances in Gene Editing Technologies in Healthcare Market Report 2023: CRISPR, ZFNs, and TALENs have Revolutionized the Gene Editing FieldFebruary 11, 2023 | usatoday.comWhat is CRISPR? What to know about the transformative gene-editing tool.December 28, 2022 | time.comHow Gene Editing Could Help Solve the Problem of Poor CholesterolDecember 20, 2022 | marketwatch.comGene Editing Market Size And Opportunities for New Players, Forecast from 2022 To 2028 with Top Countries DataNovember 24, 2022 | marketwatch.comGene Editing Market Size In 2022 : Future Scope, Demands and Projected Technology Type Growths to 2028 | 93 Report PagesSeptember 24, 2022 | msn.comGene Kelly Admitted to Terrorizing This Co-Star: 'Surprised She Still Speaks to Me.'September 12, 2022 | finance.yahoo.comGenome Editing Market to Hit $21.36 Billion by 2030, With a CAGR of 17.33% Asserts Strategic Market ResearchSeptember 8, 2022 | finance.yahoo.comGenome Editing Technologies Market Report 2022-2032September 5, 2022 | benzinga.comGenome Editing Market Size to Grow USD 6739.8 Million by 2028 at a CAGR of 9.3% | Valuates ReportsAugust 29, 2022 | finance.yahoo.comGlobal Genome Editing Market Report 2022: Continuous Technological Advancements in Gene-Editing Tools Driving GrowthAugust 25, 2022 | benzinga.comA Cellular Engineering Breakthrough: High-Yield CRISPR Without Viral VectorsAugust 24, 2022 | nasdaq.comUnlocking the Potential of Gene EditingAugust 17, 2022 | msn.comChinese scientists develop new ‘controllable and reversible’ gene-editing techniqueAugust 8, 2022 | seekingalpha.comCrispr: My Long-Term 'Wait And Watch' Punt On The Future Of Gene EditingAugust 2, 2022 | benzinga.comSNIPR Biome Granted New US Patent Covering Lytic CRISPR PhageJuly 28, 2022 | marketbeat.com3 Sectors You Might Have Missed with Upside (XDNA)Thematic ETFs are poised to become more important vehicles for accessing subindustries in very targeted ways that are not possible with broad sector funds.July 11, 2022 | finance.yahoo.comGene Editing Market Is Expected to Reach $7.4 Billion by 2031, Claims AMRJune 25, 2022 | marketwatch.comGene Editing Market : Industry Trends, Size, Growth Insight, Share, Competitive Analysis, Statistics, Regional, And Global Industry Forecast to 2027June 24, 2022 | benzinga.comWorldwide Genome Editing Industry to 2027 - North America to Dominate the Global MarketJune 22, 2022 | msn.comNovartis Follows Eli Lilly With $1.4 Billion Gene-Editing PactJune 13, 2022 | benzinga.comAdvances for India as foundational CRISPR/Cas9 gene editing patent granted Get Kelly CRISPR & Gene Editing Technology ETF News Delivered to You Automatically Sign up to receive the latest news and ratings for XDNA and its competitors with MarketBeat's FREE daily newsletter. Email Address 625,000% Gain (Ad)Imagine swapping your daily coffee expense for a future free of financial worries. It might seem far-fetched, but results like this are within reach with the right knowledge and timing in the altcoin market. Plus, you’ll get $10 in real Bitcoin when you stay to the end of the call and take a short quiz. >> Dive into the Workshop Here XDNA Media Mentions By Week XDNA Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. XDNA News Sentiment▼0.000.77▲Average News Sentiment XDNA News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. XDNA Articles This Week▼00▲XDNA Articles Average Week Get Kelly CRISPR & Gene Editing Technology ETF News Delivered to You Automatically Sign up to receive the latest news and ratings for XDNA and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies: EDUT News FBOT News LITP News Headlines Tools: Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:XDNA) was last updated on 7/27/2024 by MarketBeat.com Staff From Our Partners625,000% GainImagine swapping your daily coffee expense for a future free of financial worries. It might seem far-fetche...Crypto Swap Profits | Sponsored“Generational Bull Run” IncomingLIVE Cash Flow Workshop Event / Hosted Virtually Weds @ 7PM EST Everyone who attends will also receive 3 sp...Unstoppable Prosperity | SponsoredRare signal predicts 50% market drop - before electionThe market is near all-time highs, we're told that unemployment is low, AI's a gift to humanity, and the FED w...Behind the Markets | SponsoredThis student turned $1,300 into $45,000 in just 4 Months!With the help of S.A.M. (my new AI-powered scanner) it's now easier than ever to find these unique trades... ...Monument Traders Alliance | SponsoredCollapse of the PetrodollarThe death of the "petrodollar" seems imminent. And the implications could not be worse for Americans. Ru...Colonial Metals | SponsoredFormer Hedge Fund Manager Issues Crash PredictionOur No. 1 stock for the rare "millionaire window" opening NOW According to Wall Street legend Whitney Tilso...Stansberry Research | SponsoredBrace Yourself: Experts calling for Bitcoin to hit $100kFor the past few months, Bitcoin has been trading flat… It's been stuck around the $60,000 to $72,000 range...Crypto 101 Media | SponsoredBreaking News: Elon Musk Invents New Type of A.I. (Shocking)Could Elon's New Device be Bigger than the iPhone? According to 30-year Silicon Valley and Wall Street vete...InvestorPlace | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Kelly CRISPR & Gene Editing Technology ETF Please log in to your account or sign up in order to add this asset to your watchlist. Share Kelly CRISPR & Gene Editing Technology ETF With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.